Ambrx’s Post

View organization page for Ambrx, graphic
Ambrx

9,247 followers

Ambrx today announced that the Company will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective prior to the market open on Monday, December 18, 2023. For more information: https://bit.ly/3GEum65

Nicholas Sarlis, MD, PhD, FACP

Chief Medical Officer at CLEARA Biotech BV, leading clinical development, translational science and medical affairs in oncology projects

10mo

Dan, warm congratulations!! A great way to end this year and start 2024...! Wishing you and your teams continuing success and Godspeed!

Like
Reply
Brian Whitlock

Go-To-Market Leader | Healthcare & Life Sciences |

10mo

Congrats to the Ambrx team! Wishing you great success!

Like
Reply
Rhonda Levinson

Commercial Pharma Leader

10mo

Congratulations, Andrew. Wonderful news!

Like
Reply
Larry Samilow

Co-Founder & Managing Director at Verve Group Consulting * Data Privacy * Compliance * Regulatory

10mo

Fantastic milestone, Daniel J. O'Connor and team Ambrx!

Like
Reply
Lynda Parker

Life Sciences Executive/ Passionate Leader/ Focused on Making a Difference

10mo

Congrats Andrew!

Like
Reply
See more comments

To view or add a comment, sign in

Ambrx

9,247 followers

View Profile

Explore topics